Endocrinology Advisor

Endocrinology Advisor is a medical publication that focuses on diabetes research and treatment. The site provides articles based on case-control and longitudinal analyses, often discussing the connections between various medications and health outcomes. An article published on the site found a link between GLP-1RAs and higher rates of antidepressant dispensing.

78%

The overall score is a weighted number that takes into account conflict of interest, bias, deception and other practices that undermines the credibility of the source. It is calculated as:
Analysis.OverallConflictOfInterestScore * 0.3F + Analysis.OverallBiasScore * 0.3F + Analysis.DeceptivenessScore * 0.3F + Analysis.ReadabilityScore * 0.1F

A score that takes into consideration the content for flow, interruptions with ads, and overt search engine optimization techniques that makes the content hard to understand

The Daily's Verdict

This news site has a mixed reputation for journalistic standards. It is advisable to fact-check, scrutinize for bias, and check for conflicts of interest before relying on its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

80%

Examples:

  • Among those dispensed a GLP-1RA, 8495 also received an antidepressant (aOR, 1.44; 99% CI, 1.38-1.50).
  • Case-control analyses revealed that 2.11% of individuals dispensed antidepressants in 2022 had received a GLP-1RA between 2012 and 2021 (aOR, 1.52; 99% CI, 1.46-1.59).
  • Longitudinal analyses showed an increased odds for being dispensed an antidepressant following the dispensing of a GLP-1RA (aHR, 1.19; 99% CI, 1.12-1.27).

Deceptions

30%

Examples:

  • The primary outcome was the odds of receiving an antidepressant prescription, including selective serotonin reuptake inhibitors and non-selective monoamine reuptake inhibitors.

Recent Articles

  • GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

    GLP-1 Receptor Agonists and Psychiatric Issues: Two Cases of Depression and Suicidal Ideation Linked to Semaglutide

    Broke On: Wednesday, 08 May 2024 Two case studies presented at the American Psychiatric Association annual meeting suggest a potential link between GLP-1 receptor agonists like semaglutide and psychiatric issues, including depression and suicidal ideation. The medication, which acts on the brain to modulate food intake and reward, has been associated with approximately 60 reported cases of suicidal ideation since 2018. Further research is needed to identify specific proteins or enzymes that may exacerbate psychological conditions and contribute to these risks.